Danaparoid sodium is a heparinoid anticoagulant widely used for the prophylaxis of deep vein thrombosis and the management of patients with a history of heparin-induced thrombocytopenia. By primarily inhibiting… Read more
Danaparoid sodium is a heparinoid anticoagulant widely used for the prophylaxis of deep vein thrombosis and the management of patients with a history of heparin-induced thrombocytopenia. By primarily inhibiting factor Xa and thrombin, this mixture of glycosaminoglycans effectively prevents clot formation while offering a distinct profile from traditional heparins. To support rigorous analytical testing and quality control, our catalogue includes specialized Danaparoid sodium reference standards, including identified impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing method validation and impurity profiling, ensuring that analytical assays meet regulatory standards for sensitivity and accuracy. By utilizing these characterized reference materials, researchers and quality control professionals can reliably quantify trace components, monitor batch consistency, and maintain the high level of precision required for the development and assessment of this anticoagulant therapy.